"Carcinoma, Adenosquamous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
| Descriptor ID |
D018196
|
| MeSH Number(s) |
C04.557.435.250 C04.557.470.200.150
|
| Concept/Terms |
Carcinoma, Adenosquamous- Carcinoma, Adenosquamous
- Adenosquamous Carcinoma
- Adenosquamous Carcinomas
- Carcinomas, Adenosquamous
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Adenosquamous".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Adenosquamous".
This graph shows the total number of publications written about "Carcinoma, Adenosquamous" by people in this website by year, and whether "Carcinoma, Adenosquamous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Adenosquamous" by people in Profiles.
-
Non-Small Cell Lung Cancer Presenting as Anterior Nasal Mass and Epistaxis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096221150633.
-
Third-line Salvage Chemotherapy for Recurrent Carcinoma of the Cervix is Associated With Minimal Response Rate and High Toxicity. Am J Clin Oncol. 2018 08; 41(8):797-801.
-
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study. Br J Cancer. 2018 01; 118(2):162-170.
-
Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes? Gynecol Oncol. 2016 Dec; 143(3):617-621.
-
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol. 2010 Jan; 41(1):113-22.
-
Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol. 2007 Nov; 197(5):503.e1-6.
-
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol. 2007 May; 105(2):299-303.
-
Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group. Int J Gynecol Cancer. 2006 Mar-Apr; 16(2):660-3.
-
Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 2003 May; 89(2):267-70.